Skip to main content

S0931, Everolimus in Treating Patients With Kidney Cancer Who Have Undergone Surgery

Submitted by Anonymous (not verified) on Tue, 07/19/2022 - 18:36
  • Read more about S0931, Everolimus in Treating Patients With Kidney Cancer Who Have Undergone Surgery

A Study to Compare the Safety and Efficacy of Dysport® and Botox® in Adults With Upper Limb Spasticity.

Submitted by Anonymous (not verified) on Tue, 07/19/2022 - 18:36
  • Read more about A Study to Compare the Safety and Efficacy of Dysport® and Botox® in Adults With Upper Limb Spasticity.

Neurodevelopment of Hypoglycemic Neonates

Submitted by Anonymous (not verified) on Tue, 07/19/2022 - 18:36
  • Read more about Neurodevelopment of Hypoglycemic Neonates

Pancreatic Cancer Early Detection Program

Submitted by Anonymous (not verified) on Tue, 07/19/2022 - 18:36
  • Read more about Pancreatic Cancer Early Detection Program

Comparing Inpatient COVID-19 Outcomes in 2 Different PT Dosing Groups

Submitted by Anonymous (not verified) on Tue, 07/19/2022 - 18:36
  • Read more about Comparing Inpatient COVID-19 Outcomes in 2 Different PT Dosing Groups

A Clinical Study of Intravenous T3011 Given as a Single Agent and in Combination With Intravenous Pembrolizumab in Participants With Advanced or Metastatic Solid Tumors

Submitted by Anonymous (not verified) on Tue, 07/19/2022 - 18:36
  • Read more about A Clinical Study of Intravenous T3011 Given as a Single Agent and in Combination With Intravenous Pembrolizumab in Participants With Advanced or Metastatic Solid Tumors

A Study Assessing PG286 Ophthalmic Solution, 0.5% Compared to Its Individual Components for 28 Days

Submitted by Anonymous (not verified) on Tue, 07/19/2022 - 18:36
  • Read more about A Study Assessing PG286 Ophthalmic Solution, 0.5% Compared to Its Individual Components for 28 Days

Leveraging CHWs to Improve COVID-19 Testing and Mitigation Among CJIs Accessing a Corrections-focused CBO

Submitted by Anonymous (not verified) on Tue, 07/19/2022 - 18:36
  • Read more about Leveraging CHWs to Improve COVID-19 Testing and Mitigation Among CJIs Accessing a Corrections-focused CBO

Phase III Study to Determine Efficacy of Durvalumab in Stage II-III Non-small Cell Lung Cancer (NSCLC) After Curative Intent Therapy.

Submitted by Anonymous (not verified) on Tue, 07/19/2022 - 18:36
  • Read more about Phase III Study to Determine Efficacy of Durvalumab in Stage II-III Non-small Cell Lung Cancer (NSCLC) After Curative Intent Therapy.

Trial on the Safety and Efficacy of MLS-101 in Patients With Uncontrolled Hypertension

Submitted by Anonymous (not verified) on Tue, 07/19/2022 - 18:36
  • Read more about Trial on the Safety and Efficacy of MLS-101 in Patients With Uncontrolled Hypertension

Pagination

  • First page First
  • Previous page Previous
  • …
  • Page 45
  • Page 46
  • Page 47
  • Page 48
  • Page 49
  • Page 50
  • Page 51
  • Page 52
  • Page 53
  • …
  • Next page Next
  • Last page Last
Subscribe to